Regillo C, Berger B, Brooks L, Clark WL, et al. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology 2023 Mar 2:S0161-6420(23)00135.
PMID: 36870451